文献速递心律失常瓣膜病与结构性心脏病

法洛四联症修复术后主动标测与预防性消融降低除颤器植入率

Proactive Mapping and Preventive Ablation Reduce Defibrillator Implantation Rates in Tetralogy of Fallot.
PubMed 文献 · J Am Coll Cardiol · 2025-01-01

本研究纳入97例无既往室速的法洛四联症修复术后患者,评估主动电解剖标测及预防性传导缓慢解剖峡部消融对一级预防ICD植入选择的影响。中位随访58个月,4例发生室速且均与消融失败相关;与传统风险分层相比,主动标测与预防性消融使ICD候选者比例显著降低(11% vs 25%-51%)。

要点

  • 主动标测与预防性SCAI消融在无既往室速的rTOF患者中安全可行,成功消融率87%。
  • 预防性消融后仅11%患者仍为ICD候选者,低于指南风险分层评估的25%-51%。
  • 随访期室速事件均发生在消融失败患者,年室速风险7%/年。

核心结论

  • 无SCAI的rTOF患者长期预后良好,主动电解剖标测与预防性SCAI消融可能显著降低一级预防ICD植入率。

研究设计与样本

  • 单中心连续纳入2005-2020年97例无既往室速的rTOF患者(年龄35±16岁,57例男性),均接受电解剖标测识别室速基质。

主要发现

  • 33例(34%)存在SCAI,19例(20%)可诱发出单形性室速(其中17例为SCAI依赖性室速)。
  • 尝试SCAI消融的30例中26例(87%)成功,无并发症。
  • 中位随访58个月(Q1-Q3:30-99个月),4例(4%)发生室速,均见于消融失败患者。
  • 依据临床风险评分、AHA 2018指南(无LGE-CMR)、AHA 2018指南(有LGE-CMR)和ESC 2022指南,分别有49例(51%)、24例(25%)、31例(32%)和48例(49%)符合ICD植入条件。
  • 主动标测与预防性消融后,11例(11%)仍为ICD候选者,包括随访期全部4例室速事件患者(年室速风险7%/年)。

关键数值与推荐

  • SCAI消融成功标准:87%(26/30)尝试病例实现成功消融。
  • ICD候选资格依据:临床风险评分、AHA 2018指南(含/不含LGE-CMR信息)、ESC 2022指南、以及电解剖标测与SCAI消融结果。
  • 基于标测与消融的ICD合格条件:未消融的SCAI、远离解剖峡部的室速基质、或严重右/左心室功能障碍。

临床怎么用

  • 对无既往室速的rTOF患者可考虑主动电解剖标测识别SCAI,并对可消融靶点行预防性消融。
  • 预防性消融后仍需结合共享决策评估ICD植入,尤其对于消融失败或存在其他高危特征者。

局限性

  • 单中心回顾性设计,样本量有限(97例)。
  • ICD植入为共享决策结果,非随机对照。
  • 传统风险分层评估为回顾性应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In patients with repaired tetralogy of Fallot (rTOF) and spontaneous ventricular tachycardia (VT), transection of slow-conducting anatomical isthmus (SCAI) by ablation results in excellent long-term VT-free survival. In patients without prior VT, proactive electroanatomical mapping and preventive SCAI ablation may impact patient selection for primary prevention implantable cardioverter-defibrillator (ICD) implantation. OBJECTIVES: The purpose of this study was to evaluate long-term outcomes after proactive electroanatomical mapping and ablation of SCAI and its impact on patient selection for primary prevention ICD implantation, compared with current risk stratification methods in rTOF patients without prior VT. METHODS: Consecutive rTOF patients without prior VT who underwent electroanatomical mapping for VT substrate identification were included (2005-2020). After successful SCAI ablation, ICD implantation was offered but was subject to shared decision making. The potential eligibility for ICD implantation was retrospectively determined using the following: 1) a clinical risk score; 2) guideline-recommended risk factors (American Heart Association [AHA] 2018 guidelines without late gadolinium enhancement [LGE] on cardiac magnetic resonance [CMR] information, AHA 2018 guidelines with LGE-CMR information, European Society of Cardiology [ESC] 2022 guidelines); and 3) electroanatomical mapping and SCAI ablation results. In the latter, patients with a nontransected SCAI, VT substrates remote from anatomical isthmuses, or severe right-/left ventricular dysfunction qualified for ICDs. RESULTS: A total of 97 patients were included (age 35 ± 16 years, 57 men); 33 patients (34%) had SCAI and 19 (20%) had inducible monomorphic VT (17 of 19 SCAI-dependent VT). Successful SCAI transection was achieved in 87% (26 of 30 patients) in whom attempted, without complications. In total, 13 patients received an ICD implantation. During a median follow-up of 58 months (Q1-Q3: 30-99 months), 4 patients (4%) had VT, all after ablation failure. According to clinical risk score, AHA 2018 guidelines without LGE-CMR information, AHA 2018 guidelines with LGE-CMR information, and ESC 2022 guidelines, 49 (51%), 24 (25%), 31 (32%), and 48 patients (49%) would have qualified for ICDs, respectively. After proactive mapping and preventive ablation, 11 patients (11%) remained ICD candidates, including all 4 with a VT event during the follow-up (annual VT risk 7%/y). CONCLUSIONS: Long-term outcome of rTOF patients without SCAI is excellent. Proactive electroanatomical mapping and preventive SCAI ablation may significantly reduce primary prevention ICD implantation rates compared with current risk prediction methods.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Kimura Y, Wallet J, Brouwer C, et al. Proactive Mapping and Preventive Ablation Reduce Defibrillator Implantation Rates in Tetralogy of Fallot. J Am Coll Cardiol. 2025. PMID: 40306842. doi:10.1016/j.jacc.2025.03.523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。